• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多柔比星(阿霉素)对不同实验器官系统的毒性。

Toxicity of Doxorubicin (Dox) to different experimental organ systems.

机构信息

Innovative Green Product synthesis and Renewable Environment Development Research Group, Faculty of Environment and Labour Safety, Ton Duc Thang University, Ho Chi Minh City, Viet Nam.

School of Chemical Engineering, Yeungnam University, Gyeongsan, Gyeongbuk 38541, Republic of Korea.

出版信息

Life Sci. 2018 May 1;200:26-30. doi: 10.1016/j.lfs.2018.03.023. Epub 2018 Mar 10.

DOI:10.1016/j.lfs.2018.03.023
PMID:29534993
Abstract

Doxorubicin (Dox) is a valuable anticancer drug for hematologic and solid tumors. Yet, it can cause multi-organ toxicities in various patients. Since toxicity evaluation is a major criterion to discuss for every experiment, the current mini-review focuses on the toxicity of Dox to multiple organs and suggests the most probable mechanism. Though several mechanisms have been suggested, the role of oxidative stress remains elusive among other mechanisms and remains the most probable mechanism for cardiotoxic effect of Dox.

摘要

多柔比星(Dox)是一种用于血液系统肿瘤和实体瘤的有价值的抗癌药物。然而,它会导致不同患者出现多器官毒性。由于毒性评估是每个实验都需要讨论的主要标准,因此当前的小型综述重点关注 Dox 对多个器官的毒性,并提出了最可能的机制。尽管已经提出了几种机制,但氧化应激的作用在其他机制中仍然难以捉摸,并且仍然是 Dox 心脏毒性的最可能机制。

相似文献

1
Toxicity of Doxorubicin (Dox) to different experimental organ systems.多柔比星(阿霉素)对不同实验器官系统的毒性。
Life Sci. 2018 May 1;200:26-30. doi: 10.1016/j.lfs.2018.03.023. Epub 2018 Mar 10.
2
Underlying the Mechanisms of Doxorubicin-Induced Acute Cardiotoxicity: Oxidative Stress and Cell Death.多柔比星诱导的急性心脏毒性的机制:氧化应激和细胞死亡。
Int J Biol Sci. 2022 Jan 1;18(2):760-770. doi: 10.7150/ijbs.65258. eCollection 2022.
3
Selective A3 adenosine receptor agonist protects against doxorubicin-induced cardiotoxicity.选择性 A3 腺苷受体激动剂可预防阿霉素所致心脏毒性。
Cancer Chemother Pharmacol. 2016 Feb;77(2):309-22. doi: 10.1007/s00280-015-2937-y. Epub 2015 Dec 16.
4
Recent progress in doxorubicin-induced cardiotoxicity and protective potential of natural products.近年来多柔比星诱导心脏毒性及天然产物的保护潜力的研究进展。
Phytomedicine. 2018 Feb 1;40:125-139. doi: 10.1016/j.phymed.2018.01.009. Epub 2018 Jan 31.
5
Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity.阿霉素诱导的心脏毒性背景下的自噬与线粒体自噬
Oncotarget. 2017 Jul 11;8(28):46663-46680. doi: 10.18632/oncotarget.16944.
6
Chrysin alleviates acute doxorubicin cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis.白杨素通过抑制氧化应激、炎症和细胞凋亡来减轻大鼠急性多柔比星心脏毒性。
Eur J Pharmacol. 2014 Apr 5;728:107-18. doi: 10.1016/j.ejphar.2014.01.065. Epub 2014 Feb 6.
7
A novel self-assembly albumin nanocarrier for reducing doxorubicin-mediated cardiotoxicity.一种新型自组装白蛋白纳米载体,用于降低阿霉素介导的心脏毒性。
J Pharm Sci. 2013 May;102(5):1626-35. doi: 10.1002/jps.23455. Epub 2013 Feb 19.
8
Doxorubicin-induced Cardiotoxicity and Cardioprotective Agents: Classic and New Players in the Game.多柔比星致心肌病和心脏保护剂:游戏中的经典和新角色。
Curr Pharm Des. 2019;25(2):109-118. doi: 10.2174/1381612825666190312110836.
9
Doxorubicin: the good, the bad and the ugly effect.多柔比星:好的、坏的和丑陋的影响。
Curr Med Chem. 2009;16(25):3267-85. doi: 10.2174/092986709788803312. Epub 2009 Sep 1.
10
Insights into Doxorubicin-induced Cardiotoxicity: Molecular Mechanisms, Preventive Strategies, and Early Monitoring.多柔比星致心肌毒性的研究进展:分子机制、预防策略及早期监测。
Mol Pharmacol. 2019 Aug;96(2):219-232. doi: 10.1124/mol.119.115725. Epub 2019 Jun 4.

引用本文的文献

1
Bio-reductive Co(iii)-doxorubicin complex for cancer cell-selective delivery of doxorubicin and potent anticancer activity.用于癌细胞选择性递送阿霉素并具有强大抗癌活性的生物还原型钴(III)-阿霉素复合物。
RSC Med Chem. 2025 Aug 7. doi: 10.1039/d5md00360a.
2
Dapagliflozin Ameliorates Doxorubicin-Induced Chemobrain and Cognitive Abnormalities in Rats: Modulation of AKT/GSK-3β and Wnt/β-Catenin Pathways.达格列净改善阿霉素诱导的大鼠化疗脑及认知异常:对AKT/GSK-3β和Wnt/β-连环蛋白通路的调节
Neurochem Res. 2025 Sep 5;50(5):286. doi: 10.1007/s11064-025-04538-0.
3
Class Effect of SGLT2 Inhibitors Against Doxorubicin-Induced Cardiotoxicity via Regulating Adenosine Kinase Mediated-Cardiac Oxidative Stress.
钠-葡萄糖协同转运蛋白2抑制剂通过调节腺苷激酶介导的心脏氧化应激对阿霉素诱导的心脏毒性的类效应
Cardiovasc Drugs Ther. 2025 Aug 26. doi: 10.1007/s10557-025-07769-z.
4
Accumulation Kinetics and Biological Action of Doxorubicin in Rabbit Intervertebral Discs.阿霉素在兔椎间盘内的蓄积动力学及生物学作用
Int J Mol Sci. 2025 Jul 30;26(15):7386. doi: 10.3390/ijms26157386.
5
Oncohepatology: Navigating liver injury in the era of modern cancer therapy.肿瘤肝脏病学:现代癌症治疗时代的肝脏损伤应对策略
World J Hepatol. 2025 Jun 27;17(6):106932. doi: 10.4254/wjh.v17.i6.106932.
6
Nanobody-functionalized liposomal doxorubicin: A novel strategy for angiogenesis suppression via VEGFR2 targeting.纳米抗体功能化脂质体阿霉素:一种通过靶向血管内皮生长因子受体2抑制血管生成的新策略。
Bioimpacts. 2025 Apr 6;15:30707. doi: 10.34172/bi.30707. eCollection 2025.
7
Genetic polymorphisms as predictors of the response of hepatocellular carcinoma patients to doxorubicin chemotherapy: a genome-wide association study.基因多态性作为肝细胞癌患者对阿霉素化疗反应的预测指标:一项全基因组关联研究
Front Pharmacol. 2025 Jun 4;16:1604473. doi: 10.3389/fphar.2025.1604473. eCollection 2025.
8
Protective effect of omega-3 on reducing doxorubicin toxicity in preclinical trials.ω-3在临床前试验中对降低阿霉素毒性的保护作用。
Toxicol Rep. 2025 May 22;14:102056. doi: 10.1016/j.toxrep.2025.102056. eCollection 2025 Jun.
9
Different Mechanisms in Doxorubicin-Induced Neurotoxicity: Impact of BRCA Mutations.多柔比星诱导神经毒性的不同机制:BRCA突变的影响
Int J Mol Sci. 2025 May 15;26(10):4736. doi: 10.3390/ijms26104736.
10
The Gut-Heart Axis and Its Role in Doxorubicin-Induced Cardiotoxicity: A Narrative Review.肠道-心脏轴及其在多柔比星诱导的心脏毒性中的作用:一篇叙述性综述。
Microorganisms. 2025 Apr 9;13(4):855. doi: 10.3390/microorganisms13040855.